{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:06:26Z","timestamp":1791597986190,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Health and Medical Research Council (NHMRC) Partnership Project","award":["APP1092547"],"award-info":[{"award-number":["APP1092547"]}]},{"DOI":"10.13039\/501100001027","name":"Australian Government Department of Health and Ageing","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001027","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Australian Department of Health"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.drugalcdep.2017.10.030","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T18:16:52Z","timestamp":1512757012000},"page":"96-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting"],"prefix":"10.1016","volume":"183","author":[{"given":"Lise","family":"Lafferty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Rance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Treloar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0005","series-title":"4517.0 \u2212 Prisoners in Australia","first-page":"2016","author":"ABS","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0010","series-title":"The Health of Australia's Prisoners 2015","author":"AIHW","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/jvh.12701","article-title":"Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005\u20132014: The HITS-p study","author":"Cunningham","year":"2017","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0020","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/infdis\/jir535","article-title":"Inactivation and survival of hepatitis C virus on inanimate surfaces","volume":"204","author":"Doerrbecker","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/09687637.2013.776517","article-title":"Hepatitis C prevention education needs to be grounded in social relationships","volume":"21","author":"Fraser","year":"2014","journal-title":"Drugs Edu. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0030","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugalcdep.2012.05.008","article-title":"High-risk drug-use practices among a large sample of Australian prisoners","volume":"126","author":"Kinner","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0040","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.26387","article-title":"Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis","volume":"58","author":"Larney","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0045","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/add.12643","article-title":"A prospective study of hepatitis C incidence in Australian prisoners","volume":"109","author":"Luciani","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0050","doi-asserted-by":"crossref","first-page":"e77038","DOI":"10.1371\/journal.pone.0077038","article-title":"Hepatitis C avoidance in injection drug users: a typology of possible protective practices","volume":"8","author":"McGowan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0055","doi-asserted-by":"crossref","first-page":"022","DOI":"10.1055\/s-0034-1371007","article-title":"New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development","volume":"34","author":"Pawlotsky","year":"2014","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0060","article-title":"Practices of partnership: negotiated safety among couples who inject drugs","volume":"0","author":"Rance","year":"2016","journal-title":"Health"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5694\/mja13.11062","article-title":"Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners \u2212 2004, 2007, 2010","volume":"200","author":"Reekie","year":"2014","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0070","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1360-0443.2008.02306.x","article-title":"The social production of hepatitis C risk among injecting drug users: a qualitative synthesis","volume":"103","author":"Rhodes","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.socscimed.2017.03.012","article-title":"The intimate relationship as a site of social protection: partnerships between people who inject drugs","volume":"180","author":"Rhodes","year":"2017","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0080","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/1467-9566.ep10934410","article-title":"Risk theory in epidemic times Sex, drugs and the social organisation of \u2018risk behaviour\u2019","volume":"19","author":"Rhodes","year":"1997","journal-title":"Sociol. Health Illn."},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","article-title":"The \u2018risk environment\u2019: a framework for understanding and reducing drug-related harm","volume":"13","author":"Rhodes","year":"2002","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","article-title":"Risk environments and drug harms: a social science for harm reduction approach","volume":"20","author":"Rhodes","year":"2009","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0095","series-title":"The Coding Manual for Qualitative Researchers","author":"Salda\u00f1a","year":"2013"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0100","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0105","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1081\/JA-200030795","article-title":"Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison","volume":"40","author":"Small","year":"2005","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0110","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1186\/1471-2458-14-830","article-title":"Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs","volume":"14","author":"Snow","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0115","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1089\/apc.2010.0142","article-title":"Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration","volume":"24","author":"Swan","year":"2010","journal-title":"Aids Patient Care STDS"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0120","series-title":"World-first Hepatitis C Trial in Prisons Launched","author":"The Kirby Institute","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-015-0045-2","article-title":"Acquiring hepatitis C in prison: the social organisation of injecting risk","volume":"12","author":"Treloar","year":"2015","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0130","doi-asserted-by":"crossref","first-page":"e0162399","DOI":"10.1371\/journal.pone.0162399","article-title":"The prison economy of needles and syringes: what opportunities exist for blood borne virus risk reduction when prices are so high?","volume":"11","author":"Treloar","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0135","series-title":"A Handbook for Starting and Managing Needle and Syringe Programs in Prisons and Other Closed Settings","author":"UNODC","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0140","series-title":"Prisons and Health","author":"WHO","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0145","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/009145091304000404","article-title":"Authenticity and diversity: enhancing Australian hepatitis C prevention messages","volume":"40","author":"Winter","year":"2013","journal-title":"Contemp. Drug Prob."},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0150","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(10)60832-X","article-title":"Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward","volume":"376","author":"Wolfe","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2017.10.030_bib0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1108\/IJPH-09-2014-0032","article-title":"Injecting drug use in prison: prevalence and implications for needle exchange policy","volume":"11","author":"Wright","year":"2015","journal-title":"Int. J. Prison. Health"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617305781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617305781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T18:23:32Z","timestamp":1536258212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617305781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":31,"alternative-id":["S0376871617305781"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.10.030","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}